Cookie Consent by Free Privacy Policy Generator
News

World Atopic Eczema Day 2024: the #AtopicEczemaUnfiltered reality of patients

16 September 2024
Europe
CARE
On 14 September, World Atopic Eczema Day, patient communities around the world are coming together to raise awareness on the burden of atopic eczema, also...

EFA Community advocates for better lives for asthma and COPD patients at ERS Congress 2024

13 September 2024
Europe
Asthma , COPD
COMMUNITY
During 7-11 September, EFA participated in the European Respiratory Society (ERS) Congress 2024, held in Vienna, Austria. Our strong delegation, including...

EFA President Marcia Podestà speaks at GA2LEN Anaphylaxis and Food Allergy Forum 2024 

10 September 2024
Europe
Food Allergy
PREVENT, - Food Safety
On 5 September, the President of EFA and Food Allergy Italia Marcia Podestà, was a speaker at a scientific workshop, part of the GA2LEN Anacare Anaphylaxis...

The EU Healthy Air Coalition calls for stronger clean air measures in the EU 

09 September 2024
EU
CLIMATE CHANGE, - Air Quality
On the occasion of the International of Clean Air for Blue Skies on 7 September, EFA joined forces with its partners within the EU Healthy Air Coalition...

EFA joins a new EU4Health project: LungHealth4Life (LH4L)  

09 September 2024
EU
COMMUNITY, - Research Projects
EFA is thrilled to join the LungHealth4Life (LH4L) project aiming to boost lung health through early intervention in schools across Europe. Leading the...

EFA Project: COPD Standards of Care – Raising the bar! 

06 September 2024
Europe
COPD
COMMUNITY, - European Lung Health Group , CARE
Shaping the Future of COPD Care: From Minimum to Optimal  A Call to Action to Stop Ignoring a Silent Disease Impacting Millions  Imagine coughing...

EFA and our Belgian members - Astma en Allergiekoepel, discuss Indoor Air Quality plans with the Belgian Ministry of Health

29 August 2024
Belgium
PREVENT, - Air Quality
On 27 June, EFA and our Belgian member association - Astma en Allergiekoepel (AAK) had a joint meeting with the Belgian Federal Ministry of Health's Indoor...

EFA co-signs letter to Von der Leyen calling for Vice-President for Health, Wellbeing and Social Rights

29 August 2024
EU
PREVENT
In July, together with our partners from the EU4Health Civil Society Alliance (CSA), EFA co-signed a letter addressed to the President of the European...

Annual Report 2023: an overview of the patients agenda for allergy and airways diseases

26 August 2024
COMMUNITY
Our Annual Report 2023 reflects a year of dedication and progress in improving the lives of respiratory patients in Europe. EFA has launched a new programmatic...

EFA responds to the HTA consultation on the cooperation with the EMA

23 August 2024
EU
CARE, - Healthcare, - Medicines
EFA has actively engaged in the EU Health Technology Assessment (HTA) consultation, emphasising the importance of collaboration between HTA bodies and...

EFA calls for strong patient involvement in EU Health Technology Assessments

21 August 2024
EU
CARE, - Healthcare
EFA has responded to another proposal for legislation completing the EU Health Technology Assessment Regulation (HTAR) that will determine how individual...

EFA attends the EU Partnership for the Assessment of Risks from Chemicals (PARC) forum

14 August 2024
EU
PREVENT, - Chemicals
EFA participated in the 3rd Stakeholder Forum meeting of the Partnership for the Assessment of Risk from Chemicals (PARC), the EU-funded project advancing...

EFA is offering EUPATI Patient Expert Training Scholarships to Members – deadline extended!

05 July 2024
Asthma , COPD, Allergy
COMMUNITY, - Expert Patient Network
Since 2022, EFA has been supporting its community of members with scholarships to participate in the European Patients’ Academy on Therapeutic Innovation’s...

Salbutamol is in shortage in Europe

04 July 2024
Asthma , COPD
CARE, - Medicines
On 6 June, the European Medicines Agency (EMA) added salbutamol, a life-saving medicine for chronic respiratory disease and especially for children...

EFA contributed to the EMA review of the first critical medicines list of the EU

03 July 2024
EU
CARE, - Medicines
EFA recently contributed to the European Medicines Agency (EMA) targeted stakeholder consultation which reviewed the first Union list of critical medicines...

EFA contributes to a consultation on strategic priorities of the EU health programme for 2025

25 June 2024
Asthma , COPD, Allergy
PREVENT, CARE, CLIMATE CHANGE
Early June, EFA responded to the stakeholders’ consultation around the strategic priorities of the 2025 Annual Work Programme of the EU health programme...

Asthma inhalers and climate labelling for patients: EFA informs the new F-Gases labelling rules for MDIs

24 June 2024
EU
Asthma , COPD
CARE, - Medicines, CLIMATE CHANGE
If you have asthma or COPD, you might be using an inhaler to help you manage your disease. Some inhalers use a gas, known as propellants, which delivers...

EFA calls on the WHO to include specific priorities for allergy and lung health in the future NCD plan

24 June 2024
International
Asthma , COPD, Allergy
PREVENT
On 17 June, EFA submitted a response to a first stage consultation to update the WHO on its Global Action Plan (GAP) 2013–2020 for the prevention and...

European Lung Health Group presents the #KeepBreathing campaign to European Commission’s DG SANTE and DG CONNECT in Luxembourg

20 June 2024
EU
Asthma , COPD
COMMUNITY, - European Lung Health Group
On 13 June, representatives from EFA and the European Respiratory Society (ERS), travelled to Luxembourg on behalf of the European Lung Health Group (ELHG)...

EFA attends EU HTA Stakeholder Network meeting in Brussels

18 June 2024
EU
COMMUNITY, CARE
The EU HTA Stakeholder Network meeting focused on the involvement of patients in the Health Technology Assessment (HTA) process. Together with the European...